Northern Trust
ADPT icon

Northern Trust’s Adaptive Biotechnologies ADPT Stock Holding History

Northern Trust’s Portfolio ADPT Stock Details ADPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$32.3M Buy
1,507,351
+115,019
+8% +$1.76M ﹤0.01% 1497
2026
Q1 		$19.3M Buy
1,392,332
+219,538
+19% +$3.5M ﹤0.01% 1704
2025
Q4 		$19M Sell
1,172,794
-59,011
-5% -$963K ﹤0.01% 1694
2025
Q3 		$18.4M Sell
1,231,805
-2,139
-0.2% -$26.1K ﹤0.01% 1740
2025
Q2 		$14.4M Buy
1,233,944
+180,354
+17% +$1.64M ﹤0.01% 1854
2025
Q1 		$7.83M Sell
1,053,590
-40,391
-4% -$310K ﹤0.01% 2183
2024
Q4 		$6.56M Buy
1,093,981
+130,449
+14% +$719K ﹤0.01% 2356
2024
Q3 		$4.93M Buy
963,532
+35,651
+4% +$155K ﹤0.01% 2484
2024
Q2 		$3.36M Sell
927,881
-96,250
-9% -$306K ﹤0.01% 2618
2024
Q1 		$3.29M Sell
1,024,131
-18,854
-2% -$73K ﹤0.01% 2721
2023
Q4 		$5.11M Buy
1,042,985
+8,163
+0.8% +$37.2K ﹤0.01% 2495
2023
Q3 		$5.64M Sell
1,034,822
-14,235
-1% -$94.1K ﹤0.01% 2372
2023
Q2 		$7.04M Buy
1,049,057
+16,351
+2% +$122K ﹤0.01% 2297
2023
Q1 		$9.12M Buy
1,032,706
+37,297
+4% +$329K ﹤0.01% 2079
2022
Q4 		$7.6M Sell
995,409
-170,425
-15% -$1.33M ﹤0.01% 2196
2022
Q3 		$8.3M Buy
1,165,834
+154,272
+15% +$1.45M ﹤0.01% 2119
2022
Q2 		$8.18M Buy
1,011,562
+547,304
+118% +$4.81M ﹤0.01% 2181
2022
Q1 		$6.44M Sell
464,258
-2,149
-0.5% -$33.8K ﹤0.01% 2427
2021
Q4 		$13.1M Sell
466,407
-11,813
-2% -$362K ﹤0.01% 2058
2021
Q3 		$16.3M Buy
478,220
+15,154
+3% +$548K ﹤0.01% 1939
2021
Q2 		$18.9M Buy
463,066
+43,596
+10% +$1.69M ﹤0.01% 1922
2021
Q1 		$16.9M Buy
419,470
+9,534
+2% +$516K ﹤0.01% 1953
2020
Q4 		$24.2M Buy
409,936
+707
+0.2% +$36.5K ﹤0.01% 1658
2020
Q3 		$19.9M Buy
409,229
+49,463
+14% +$2.08M ﹤0.01% 1634
2020
Q2 		$17.4M Sell
359,766
-14,785
-4% -$539K ﹤0.01% 1739
2020
Q1 		$10.4M Buy
374,551
+261,558
+231% +$7.3M ﹤0.01% 1852
2019
Q4 		$3.38M Sell
112,993
-701
-0.6% -$20.1K ﹤0.01% 2815
2019
Q3 		$3.51M Buy
+113,694
New +$4.64M ﹤0.01% 2758

Other funds holding ADPT

Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Northern Trust's ADPT Position: Q2 2026 in Review

Northern Trust increased its Adaptive Biotechnologies (ADPT) stake by 8.3% in Q2 2026, buying an estimated $1.76M and bringing the position to 1,507,351 shares worth $32.3M. The position accounts for ﹤0.01% of the portfolio, ranked #1497.

Northern Trust first reported a position in ADPT in Q3 2019 and has held it in 28 quarters since. 300 funds tracked by Wall St. Rank hold ADPT as of Q2 2026.

  • Northern Trust held 1,507,351 shares of Adaptive Biotechnologies worth $32.3M as of Q2 2026.
  • Northern Trust bought 115,019 Adaptive Biotechnologies shares in Q2 2026, an estimated $1.76M.
  • Adaptive Biotechnologies made up ﹤0.01% of Northern Trust's portfolio in Q2 2026, its #1497 holding.
  • Northern Trust first reported a position in Adaptive Biotechnologies in Q3 2019 and has held it in 28 quarters since.
  • 300 funds tracked by Wall St. Rank held Adaptive Biotechnologies as of Q2 2026.

Based on Northern Trust's 13F filing for Q2 2026, filed 13 Aug 2026.